Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Kidd

Showing results (141-150 of 162) with videos related to

Pageof 17
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 1, 2014
Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signalingSimon Schimmack, Andrew Taylor, Ben Lawrence, et al.
Cancer|May 1, 2007
Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1Mark Kidd, Irvin M Modlin, Roswitha Pfragner, et al.
The Prostate|April 4, 2024
Development of a multigenomic liquid biopsy (PROSTest) for prostate cancer in whole bloodIrvin M Modlin, Mark Kidd, Ignat A Drozdov, et al.
Histology and Histopathology|February 8, 2013
Immunohistochemical evidence for an impairment of autophagy in tumorigenesis of gastric carcinoids and adenocarcinomas in rodent models and patientsReidar Alexander Vigen, Yosuke Kodama, Trond Viset, et al.
Scandinavian Journal of Gastroenterology|May 17, 2015
The guanylate cyclase-C signaling pathway is down-regulated in inflammatory bowel diseaseØystein Brenna, Torunn Bruland, Marianne W Furnes, et al.
International Journal of Medical Sciences|April 16, 2021
A combination of surgery, theranostics, and liquid biopsy - a personalised oncologic approach to treatment of patients with advanced metastatic neuroendocrine neoplasmsAndrea Frilling, Ashley K Clift, Adam E Frampton, et al.
Endocrine Connections|January 21, 2017
Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systemsAshley K Clift, Omar Faiz, Robert Goldin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2014
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factorsLisa Bodei, Mark Kidd, Giovanni Paganelli, et al.
Journal of Thoracic Disease|December 5, 2017
Molecular strategies in the management of bronchopulmonary and thymic neuroendocrine neoplasmsIrvin M Modlin, Mark Kidd, Pier-Luigi Filosso, et al.
Journal of Surgical Oncology|August 17, 2018
Measurement of circulating transcript levels (NETest) to detect disease recurrence and improve follow-up after curative surgical resection of well-differentiated pancreatic neuroendocrine tumorsCansu G Genç, Anneke P J Jilesen, Els J M Nieveen van Dijkum, et al.
Pageof 17

Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 1, 2014
Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signalingSimon Schimmack, Andrew Taylor, Ben Lawrence, et al.
Cancer|May 1, 2007
Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1Mark Kidd, Irvin M Modlin, Roswitha Pfragner, et al.
The Prostate|April 4, 2024
Development of a multigenomic liquid biopsy (PROSTest) for prostate cancer in whole bloodIrvin M Modlin, Mark Kidd, Ignat A Drozdov, et al.
Histology and Histopathology|February 8, 2013
Immunohistochemical evidence for an impairment of autophagy in tumorigenesis of gastric carcinoids and adenocarcinomas in rodent models and patientsReidar Alexander Vigen, Yosuke Kodama, Trond Viset, et al.
Scandinavian Journal of Gastroenterology|May 17, 2015
The guanylate cyclase-C signaling pathway is down-regulated in inflammatory bowel diseaseØystein Brenna, Torunn Bruland, Marianne W Furnes, et al.
International Journal of Medical Sciences|April 16, 2021
A combination of surgery, theranostics, and liquid biopsy - a personalised oncologic approach to treatment of patients with advanced metastatic neuroendocrine neoplasmsAndrea Frilling, Ashley K Clift, Adam E Frampton, et al.
Endocrine Connections|January 21, 2017
Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systemsAshley K Clift, Omar Faiz, Robert Goldin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2014
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factorsLisa Bodei, Mark Kidd, Giovanni Paganelli, et al.
Journal of Thoracic Disease|December 5, 2017
Molecular strategies in the management of bronchopulmonary and thymic neuroendocrine neoplasmsIrvin M Modlin, Mark Kidd, Pier-Luigi Filosso, et al.
Journal of Surgical Oncology|August 17, 2018
Measurement of circulating transcript levels (NETest) to detect disease recurrence and improve follow-up after curative surgical resection of well-differentiated pancreatic neuroendocrine tumorsCansu G Genç, Anneke P J Jilesen, Els J M Nieveen van Dijkum, et al.
Pageof 17